Popular Articles

Molecule Helps Breast Cancer Cells To Survive In The Bone Marrow
Patients who survive an initial diagnosis of breast cancer often succumb to the disease years later when the cancer shows up in a different part of the body. Now, scientists have identified key signals that support the long term survival of breast cancer cells after they have spread to the bone marrow. The research, published by Cell Press in the July issue of the journal Cancer Cell, may lead to development of treatment strategies that decrease the likelihood of breast cancer recurrence in the bone and other organs.

ACCP Position Paper On Genetic Tests Advertised Directly To The Consumer
Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers" response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, according to a position paper from the American College of Clinical Pharmacology (ACCP) to be published in the August 2009 issue of the Journal of Clinical Pharmacology. The journal is published on behalf of the ACCP by SAGE.
News of the day
Increasing ICS Compliance: The Voice May Be Recorded, But The Results Are Real
Automated phone calling may help physicians solve a perennial problem: patients who don"t take medicine prescribed for chronic health conditions.
Sexual Health

D.C. Federal Court Rules People With Diabetes Cannot Be Denied Employment Based On Disease Management

Yesterday, a jury in the United States District Court for the District of Columbia found that the Federal Bureau of Investigation (FBI) discriminated against Jeff Kapche when it refused to hire him as a Special Agent because of his diabetes. The American Diabetes Association (ADA) celebrated the verdict. "ADA has long advocated that each person with diabetes should be judged based on his or her merits, not on stereotypes. This is an important victory as we march towards a world in which each person with diabetes is judged fairly," said John Griffin, Vice-Chair of the American Diabetes Association and one of the lawyers who represented Kapche. In the case, Kapche v. Holder, the FBI contested that Jeff Kapche, a 15-year law enforcement veteran, could not perform the job of an FBI Special Agent because he chose to manage his type 1 diabetes with insulin injections. The FBI argued that its policy requiring Special Agents to manage their diabetes with insulin pumps was necessary given the unpredictable nature of the job, ignoring both medical evidence about injection therapy and Kapche"s own impeccable record of diabetes management without complications. "I am thrilled the jury understood that the FBI"s decision was discriminatory and that I could be a good Special Agent," said Kapche. "I don"t want anyone else to go through what I have experienced and I hope this jury verdict sends the message that employers should look at each person as an individual, not simply someone with a disease." Kapche was also represented by Kathy Butler, a member of ADA"s Legal Advocacy Subcommittee. "The jury understood that ignorance of diabetes leads to discrimination and that is just plain wrong. Because of Jeff Kapche, others with diabetes no longer need to check their dreams at the door," said Butler. Kapche, who is currently a detective with the Fort Bend County, Texas Sheriff"s Department, had previous experience fighting discrimination when he was denied employment with the San Antonio Police Department, also because of his diabetes. That case wound up in the United States Court of Appeals for the Fifth Circuit which ruled such blanket bans were unlawful. Before applying to the FBI, Kapche was assured that his diabetes would not stand in the way of his becoming a Special Agent. American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):